Article

Psychedelic Policies in Canada: Separating Hallucinations from Reality

Highlights Cannabis use for medical purposes bypassed the traditional drug policy protocols before the introduction of the Cannabis Act through successive court decisions suspending it from the Canadian Substance Drugs Act (CSDA). Psychedelics, such as psilocybin and MDMA, are following Health Canada’s standard protocols for clinical trial phases. Full legalization of psychedelics for recreational use

Psychedelic Policies in Canada: Separating Hallucinations from Reality Read More »